Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT1 | P54687 | 6/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | BCAT2 | O15382 | 4/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.34 |
| ▸ | GNRHR | P30968 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3246458 | 0.92 | BCAT1 (0.38) | BCAT1POLBL3MBTL1SMN1; SMN2GLA | |
| SCHEMBL6245829 | 0.92 | PKM (0.39) | BCAT1POLBL3MBTL1SMN1; SMN2GLA | |
| SCHEMBL29452779 | 0.92 | BCAT1 (0.39) | BCAT1POLBL3MBTL1SMN1; SMN2GLA | |
| SCHEMBL3245244 | 0.92 | BCAT1 (0.39) | BCAT1POLBL3MBTL1SMN1; SMN2GLA | |
| SCHEMBL6263807 | 0.89 | BCAT1 (0.50) | BCAT1BCAT2 | |
| SCHEMBL3248247 | 0.89 | ALDH1A1 (0.37) | BCAT1POLBBCAT2PTGDR2ALDH1A1 | |
| SCHEMBL31143246 | 0.85 | MEN1 (0.38) | BCAT1POLBL3MBTL1SMN1; SMN2GLA | |
| SCHEMBL27047534 | 0.85 | LMNA (0.41) | BCAT1SMN1; SMN2PKMBCAT2PTGDR2 | |
| SCHEMBL27047538 | 0.85 | PKM (0.45) | BCAT1POLBSMN1; SMN2PKMPTGDR2 | |
| SCHEMBL27044947 | 0.84 | BCAT1 (0.39) | BCAT1POLBBCAT2BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1106607-B1 | Uracil compounds and their use | SUMITOMO CHEMICAL CO (JP) | 2005-07-27 | — | — | EP | disclosed |
| US-6667413-B2 | Aniline derivatives; herbicides; nonphytotoxic | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-12-23 | — | — | US | disclosed |
| US-20030130124-A1 | Herbicides | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-07-10 | — | — | US | disclosed |
| US-6451740-B2 | HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-09-17 | — | — | US | disclosed |
| US-20020013466-A1 | Uracil compounds and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-31 | — | — | US | disclosed |
| EP-1106607-A2 | Uracil compounds and their use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130124-A1 | Herbicides | CBR3, CBR1, MT-CO1 | BCAT1 492/4885POLB 950/4885L3MBTL1 295/4885 |
| US-20020013466-A1 | Uracil compounds and use thereof | UNG, MRM1, OGG1 | BCAT1 450/4885POLB 207/4885L3MBTL1 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.